Additional Listing

Additional Listing November 26, 2013 - Shire plc (the "Company") (LSE: SHP, NASDAQ: SHPG) herebynotifies the market that an application has been made to the UK ListingAuthority and the London Stock Exchange for a total of 766,840 ordinary sharesof 5p each to trade on the London Stock Exchange and to be admitted to theOfficial List. When issued, these shares will rank equally with the existing issued ordinaryshares of the Company. These shares are to be issued following receipt of bond conversion notices forthe Shire plc 2.75% Convertible Bonds due 2014. For further information please contact: Investor Relations Eric Rojas [email protected] +1 781 482 0999 Sarah Elton-Farr [email protected] +44 1256 894157 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,Internal Medicine and Regenerative Medicine and we are developing treatmentsfor symptomatic conditions treated by specialist physicians in other targetedtherapeutic areas. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com